Goldman Sachs analyst Alexander Blostein lowered the firm’s price target on State Street (STT) to $98 from $100 and keeps a Buy rating on the shares after its Q1 results. The company beat on earnings, but the firm is cutting its FY25 EPS view by 35c to $9.31 to reflect weaker markets backdrop for fees and a lower jumping off point for net interest income heading into Q2, the analyst tells investors in a research note. Goldman adds however that the firm is encouraged by the management sticking with their original 2025 guide across revenues, expenses, and positive operating leverage.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STT:
- State Street says outlook remains unchanged despite macro uncertainty
- State Street says CFO announcement should come soon
- Morning Movers: UnitedHealth plummets following Q1 results and guidance cut
- State Street Reports Strong Q1 2025 Earnings Growth
- State Street reports Q1 EPS $2.04, consensus $2.01